Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes (Q61956189)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
clinical trial

    Statements

    A Multi-National, Multi-Centre, Randomised, Open-Labelled, Parallel Trial Comparing Efficacy and Safety of NovoMix® 30 FlexPen® and Mixtard® 30 Twice Daily Injections in Subjects With Type 2 Diabetes (English)
    0 references
    0 references
    0 references
    0 references
    19 August 2002
    0 references
    15 May 2003
    0 references
    292
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit